General Western Blot Reagents
Abcam Gly-Phe beta-naphthylamide, Cathepsin C substrate, 100MG
MW 347.41 g/mol, Purity >95%. Substrate for the lysosomal cysteine protease Cathepsin C. Accumulates within the lysosome. Hydrolysis by cathepsin C degrades Gly-Phe-β-naphthylamide into fragments that do not easily diffuse through the lysosomal membrane, leading to a loss of lysosome membrane integrity. Used to study intralysosomal hydrolysis, lysosomal membrane permeability, and the function of cathepsin C. Inhibits the cathepsin-dependent activation of caspase-8.
The product is subject to the following: Abcam Restricted Use Statement
Abcam BHHCT, Fluorescent sensitizer for Eu3+- labelling, 5MG
MW 804.9 Da, Purity >90%. Fluorescent sensitizer for Eu3+- labelling. Increases luminescence intensity 11 fold. Persists as an Eu3+ complex for 500 μs typical of the Eu3+ oxidation state. Measures peroxidase activity and oxidative stress levels.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Raffinose pentahydrate, Trisaccharide, 25G
MW 594.5 g/mol, Purity >98%. Trisaccharide composed of galactose, fructose, and glucose. Hydrolysed to D-galactose and sucrose by D-galactosidase.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Verapamil hydrochloride (mM/ml), L-type Ca2+ channel blocker, 50MM_ML
MW 491.1 Da, Purity >99%. L-type Ca2+ channel blocker. Antiarrhythmic in vivo. Soluble in 1 ml water to give specified mM/ml concentration.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Nocardamine (Deferrio x amine E), Antibiotic agent, 5MG
MW 600.7 Da, Purity >95%. Antibiotic agent. Siderophore iron chelator. Induces morphological changes in insect cells. Shows weak antimicrobial against Gram-positive bacteria.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Acetosyringone, phenolic compound, 1G
MW 196.2 g/mol, Purity >98%. Naturally occurring phenolic compound found in plants and used in plant-pathogen recognition. Effective inducer of the virulence genes of Agrobacterium tumefaciens. Used in the synthesis of tetramethoxychalcone and its analogues as anticancer agents invitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Mouse Cathelicidin/CLP peptide, 1MG
Mouse Cathelicidin/CLP peptide is a Synthetic blocking peptide. >70% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: CAP18, FALL39, HSD26, CAMP, Cathelicidin antimicrobial peptide, 18 kDa cationic antimicrobial protein, CAP-18, hCAP-18
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Doceta x el, Cytoto x ic agent, 10MG
MW 807.9 Da, Purity >99%. Potent cytotoxic agent in vitro (IC₅₀ = 2 nM). Disrupts microtubule assembly and arrests cell divison at G₂/M phase. Induces apoptosis. Antitumor agent. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ghrelin (human), Endogenous GHS agonist, 1MG
MW 3370.91 g/mol, Purity >95%. Endogenous agonist peptide for the ghrelin (GHS) receptor. Stimulates release of growth hormone from the pituitary gland and regulates feeding, appetite, growth and energy homeostasis.
The product is subject to the following: Abcam Restricted Use Statement
Abcam tBuBHQ (BHQ), Sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor, 100MG
MW 222.32 Da, Purity >99%. Sarco-endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitor. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Tamo x ifen citrate, Estrogen receptor antagonist and partial agonist, 100MG
MW 563.65 g/mol, Purity >99%. Competitive estrogen receptor antagonist and partial agonist. Inhibits estrogen dependent gene transcription and tumor growth. Additionally decreases cardiac infarction and inhibits Kir2.1, Kir2.2 and Kir2.3 potassium channels (IC₅₀ values are 0.93, 0.87 and 0.31 μM, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Nullscript, Inactive analog of scriptaid, 5MG
MW 298.3 g/mol, Purity >97%. Inactive analog of histone deacetylase (HDAC) inhibitor scriptaid (ab120883). Used as a negative control.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 271046 hydrochloride, 5-HT6 antagonist, 10MG
MW 488.45 g/mol, Purity >99%. Potent and selective 5-HT₆ receptor antagonist (Ki = 1-2 nM). Displays >200-fold selectivity for 5-HT₆ receptors (vs. other receptor binding sites and ion channels). Poor penetration of the blood-brain barrier. Nootropic effects in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bezafibrate, Pan-PPAR agonist, 5G
MW 361.8 Da, Purity >99%. Pan-PPAR agonist (EC₅₀ values are 50, 60 and 20 μM at PPARα, PPARγ and PPARδ human receptors respectively). More efficient than fenofibrate (ab120832) in reducing body weight and blood glucose. Antidiabetic and antihyperlipidemic effects.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Antibiotic PF 1052, Neutrophil migration inhibitor, 500UG
MW 429.59 g/mol, Purity >98%. Neutrophil migration inhibitor. Antibacterial and potentially antifungal and phytotoxic properties. Active in vivo and in vitro. See similar compound
The product is subject to the following: Abcam Restricted Use Statement